CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced a new large-volume electroporation system that allows cell therapy developers to more ...
Protocols are often identified through costly trial-and-error, and can vary significantly from lab-to-lab and application-to-application. The Rutgers interdisciplinary research and development team ...
Predictive value of baseline 68Ga-FAPI PET/CT in the first-line therapy of pancreatic ductal adenocarcinoma (PDAC). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
Irreversible electroporation using the NanoKnife System provided effective focal therapy option for intermediate-risk prostate cancer, with mostly favorable oncologic and functional outcomes. For ...
Genetic disorders such as cystic fibrosis and long QT syndrome are caused by mutations in human ion channel and ion transporter genes. Electroporation is a non-viral transfection technique ...
Immunotherapy or adoptive cell therapy has been hailed as a game changer for cancer treatment. It involves harnessing the power of the body’s own immune system to help fight cancer. T-cells are key ...
insights from industryJames BradySenior Vice PresidentMaxCyte, Inc. In this interview, NewsMedical talks to James Brady about cell-based therapy and how the field of genetic engineering transformed.
MaxCyte Inc., announced the launch of ExPERT DTx™, a new high throughput transfection platform for research and drug discovery applications. This modular, 96-well electroporation system enables labs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results